Can B Corp (CANB)

[Penny Masters]

3rd RS for CANB? True value Pre-RS's .000's and headed lower. Not sure what they can do to keep the doors open much longer as they have bloated salaries, MASSIVE debt and product few ever heard of or know.

Hope some did not lose more than they can afford to in this train wreck.

Peace out

[skyhawk66]

Spot On BG, investors care. No wonder shares are in Strong Hands and Accumulation Continues Weekly and Monthly during this slow period.
In the meantime….Calm Cool and Collecting at these Oversold Level.
Nothing like a Sweet Vacation with Salami Profits $$$$$, Congrats :)
:
“Calm, cool and collected. Had an excellent vacation with grand salami $$$

MJ/Hemp sector will see a resurgence. Not a CANB issue but a market and economy issue. “

CANB



The Badguy

[waterchaser]

Nobody cares about CANB.
It’s old, worn out salami news.

[Penny Masters]

Who cares? CANB is done.

Peace out

[badguy3101]

Calm, cool and collected. Had an excellent vacation with grand salami $$$

MJ/Hemp sector will see a resurgence. Not a CANB issue but a market and economy issue.

CANB



The Badguy

[Penny Masters]

CANB would need to be at what 30.00 pre-RS's for any to break even. Maybe a 3rd RS would get you to 5.00 but the real value is now .000's from all the previous RS's.

They will most likely close or change sectors soon based on the massive debt, bloated salaries and products few ever heard of or seem to want.

Peace out

[CHnJUP]

Interesting trading today so far.
600 shares Buty at 1.00
Min later sell a 1000 shares at 90 cents. Buy at 75 cents 400 shares some more at 70 cents what is going on?
Any chance we get back where we were at the r/s? Hope so I'm on the bridge looking at the surf right now

[Penny Masters]

Hahahaha that was a earlier WDRP scam. The new and updated is the NFT's,,, no no no,,, it is now EV car parts from a coffee company. LOLOLOL.

Cannot make this stuff up.

[waltczyk]

REDWOOD BABY !!!!!!!\

[Penny Masters]

CANB - LOOK OUT BELOWWWWW!!!! Finally this thing is done. The money lost has to be immense.

Peace out

[waterchaser]

CANB = Grand Salami implosion.

[waterchaser]

Great CANB news!

CANB WILL NOT LOSE FURTHER VALUE ON MONDAY (tomorrow).

What a relief!

[Penny Masters]

Is CANB allowed a 3rd RS? They will need it. We all knew the ending here. Nasty what was done to share holders and it looks like it is finally done.
Peace out

[waterchaser]

Now $.77? Isn't $1.00 required for NASDAQ?
Ouch!

[waterchaser]

Further away today from the $1 threshold.
$.80 ain’t good.
With the CANB promo dying out, I don’t see a good ending here.

[waterchaser]

Epic scam OTC Pump and Dump.
CANB will go down in history as the biggest scam OTC pump in history.

[Penny Masters]

Fat lady sang, Elvis left the building. Stick a fork in as the CANB shit is done.

Peace out

[waterchaser]

What a shit-show the CANB promo ended-up being.

I knew from the first day I found CANB that the promo wasn't going to end well.
These things are always front-loaded and promoted to high heaven so the front-loaders can unload their worthless shares.

After unloading, they laugh their way back from the bank... laughing at the dupes that thought they were going to get rich on MJ.

I'm sure glad I didn't buy the CANB hype!

I didn't lose a dime to the CANB promo... it wasn't as slick as some thought.

[Penny Masters]

Can CANB legally do another RS? Going to have to do a 3rd or 4th RS to keep the price high enough for NASDAQ. LOLOLOLOLOL!

Finally this sleek salesman garbage is coming to a end.

Peace out

[waterchaser]

Uh oh! PPS dropped below $1 today.
Could be a big selling day tomorrow as players fear the worst here.

[Penny Masters]

All know the ending here and not sure anyone can keep the CANB charade afloat much longer. Bloated salaries, MASSIVE debt and products no one wants. What could go wrong with that?

Peace out

[waterchaser]

Investors-are-desperately trying to keep CANB above $1.

[waterchaser]

Downhill ski-slope chart formation!

Six month chart looks to be a slippery slope, ha!

The CANB warnings have been plentiful and omnipresent... buyer beware.

[Penny Masters]

CANB needs another RS to get back to NASDAQ numbers. LOL That will put them under .0001 from the original value pre-RS's. Cannot understand why these try to continue to fool anyone?

How much money does this trainwreck lose before they officially close the doors.

Peace out

[waterchaser]

On standby for RS news.

[waterchaser]

Is that when the next RS will be announced?

[skyhawk66]

Misleading. Facts Now, anyone know when the 3rd Consecutive Record Quarter will be posted?

[waterchaser]

Anyone heard when the next CANB reverse split is planned?

[skyhawk66]

Strong Accumulation EOD…Again Point proven,
Smart Money wants a piece of this undervalued gem, especially at these Oversold Levels.
Never too late to get back in before it takes of 2023 and Beyond.

No Denying it , Consecutive Record Breaking Quarters Speaks Volumes, Facts.

[Penny Masters]

Crappy outdated product, bloated salaries and more RS's to come as CANB is a train wreck that never stops wrecking.

Name any products anywhere that someone even heard of or buys. They are done and will change sectors soon as no one wants what they are selling and NO ONE would buy the junk shares they are selling.

Mark it and peace out.

[skyhawk66]

Yawn..notice how CANB shares are in tight hands,,very low volume on down days.
Easy to see why,,Another Record Quarter back to back.
Here are the Key Highlights to help with the Facts. Key sentence at the end-

“a reduction in cash losses.”

:

Key Financial Highlights for Q3 2022

Revenue increased 51% to $2.9 million

Gross profit increased 36% to $1.9 million

Gross margin decreased to 64.3%

Adjusted EBITDA loss decreased by 25% to $1.5 million

Accounts receivable at $7.0 million

Inventory at $2.3 million

Total assets at $16.7 million

Total stockholders’ equity at $4.5 million

Key Financial Highlights for 9 Months Ended September 30, 2022

Revenue increased 130% to $6.0 million

Gross profit increased 59% to $2.8 million

Gross margin decreased to 46.0%

Adjusted EBITDA loss decreased by 15% to $4.5 million

Key Business Highlights for Q3 2022

Signed Manufacturing and Distribution Agreement for Superfood Products with Forever Brands and Brooke Burke via BB Body, Inc.

Consolidated Hemp Division Operations in Colorado

Management Commentary

Marco Alfonsi, Can B’s Chief Executive Officer, stated, “We are thrilled with our tremendous quarterly results, having achieved the highest quarterly revenue in our company history. We generated $2.9 million in quarterly revenue while reducing our cash burn as demonstrated by the 25% decrease in Adjusted EBITDA. Our team made great strides over the past several months integrating and ramping up the various operations we strategically acquired over the past year to complete our vertical processing capabilities.”

Alfonsi concluded, “We had a vision and were confident in the assets we were assembling over the past year. It is great to see all the challenging work pay off and result in accelerating revenue growth and a reduction in cash losses.

[Penny Masters]

Looks like the next record is lowest price ever for the CANB trainwreck. You do know after the RS's the real value is now in trips and will approach .0000's shortly.

Peace out

[Penny Masters]

Maybe they will lose 15 million this Q. Go CANB. LOLOLOLOL

What a train wreck and not sure they are allowed any more RS's as they had a bunch.

Peace out

[skyhawk66]

Getting ready for CANB Next Record Quarter, so much for negative Opinions that is forgotten as soon as it’s….
Facts Now:
$$$$
As Forecasted, Another Record Quarterly Revenue Record for CANB!
Can B Corp. Reports Growth of 51% to $2.9 Million Revenue for Third Quarter 2022, the Highest Quarterly Revenue in Company History

Can B Corp
Tue, November 22, 2022 at 9:30 AM
In this article:

Can B Corp

Led by a Significant Increase in Duramed, Music City Botanical and Botanical Biotech Brands

Adjusted EBITDA Loss Decreased by 25% to $1.5 Million

HICKSVILLE, NY, Nov. 22, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Can B Corp. (OTCQB: CANB) (“Can B” or the “Company”), a health and wellness company specializing in developing, producing, and selling hemp-derived cannabinoid products, today announced the Company's financial results for the third quarter and nine months ended September 30, 2022.

Key Financial Highlights for Q3 2022

Revenue increased 51% to $2.9 million

Gross profit increased 36% to $1.9 million

Gross margin decreased to 64.3%

Adjusted EBITDA loss decreased by 25% to $1.5 million

Accounts receivable at $7.0 million

Inventory at $2.3 million

Total assets at $16.7 million

Total stockholders’ equity at $4.5 million

Key Financial Highlights for 9 Months Ended September 30, 2022

Revenue increased 130% to $6.0 million

Gross profit increased 59% to $2.8 million

Gross margin decreased to 46.0%

Adjusted EBITDA loss decreased by 15% to $4.5 million

Key Business Highlights for Q3 2022

Signed Manufacturing and Distribution Agreement for Superfood Products with Forever Brands and Brooke Burke via BB Body, Inc.

Consolidated Hemp Division Operations in Colorado

Management Commentary

Marco Alfonsi, Can B’s Chief Executive Officer, stated, “We are thrilled with our tremendous quarterly results, having achieved the highest quarterly revenue in our company history. We generated $2.9 million in quarterly revenue while reducing our cash burn as demonstrated by the 25% decrease in Adjusted EBITDA. Our team made great strides over the past several months integrating and ramping up the various operations we strategically acquired over the past year to complete our vertical processing capabilities.”

Alfonsi concluded, “We had a vision and were confident in the assets we were assembling over the past year. It is great to see all the challenging work pay off and result in accelerating revenue growth and a reduction in cash losses. With our proven manufacturing and distribution capabilities, we are now executing major strategic agreements, such as the recently announced deal with Brooke Burke. Since the end of the quarter, we have started taking orders and shipping Superfood Products with Brooke Burke and are very excited about the early demand and results. Can B is now a full-service hemp-derived cannabinoid company that can facilitate servicing large box retailers, boutique vape and smoke stores, and strategic partners.”

Manufacturing and Distribution Agreement for Superfoods Products with Forever Brands and Brooke Burke via BB Body, Inc.

The initial 3-year worldwide agreement covers the sale, manufacturing, and distribution of Superfoods and related nutritional products. Can B subsidiaries Imbibe Wellness Solutions is the exclusive direct-to-consumer seller of the products and Pure Health Products is a manufacturer and distributor of the products. The products will be marketed under the Longevity by Brooke Burke trademarks and brand. The partnership includes a powdered drink superfood mix, an all-natural metabolic energy drink, and other products that may be mutually agreed from time to time.

Brooke Burke, an American television personality, fitness personality, author, actress, and businessperson, will market, endorse, and promote the products as a monthly online subscription model under her company BB Body, Inc.

Subsequent to the end of the third quarter, the product launched.

Financial Results for the Three Months Ended September 30, 2021:

Revenue: For the three months ended September 30, 2022, revenue was $2.9 million, an increase of $1.0 million, or 51%, compared with $1.9 million for the three months ended September 30, 2021. The increase is due to the ` winddown of restrictions related to the Covid-19 Pandemic surrounding elective surgeries, enabling an increase in the usage of the Company’s Duramed product lines and ultrasound devices associated with patient recovery. Additionally, due to asset acquisitions in 2021, the Company’s Music City Botanical and Botanical Biotech brands related to an increase of sales compared to 2021 of approximately $1.5 million.

Gross Profit: For the three months ended September 30, 2022, gross profit was $1.9 million, an increase of $0.5 million, or 36%, compared with $1.4 million for the three months ended September 30, 2021. The resulting gross margin was 64.3%, compared with 71.7% for the same quarter last year.

Total Operating Expenses: For the three months ended September 30, 2022, total operating expenses were $8.7 million, an increase of $4.8 million, or 223%, compared with $3.9 million for the same quarter last year. The increase in operating expenses was primarily due to the non-cash stock-based compensation expense of $4.5 million and $0.8 million of other non-cash and non-recurring one-time items.

Operating Loss: For the three months ended September 30, 2022, operating loss was $6.8 million, an increase of $4.3 million, or 271%, compared with an operating loss of $2.5 million for the same quarter last year.

Adjusted EBITDA Loss: For the three months ended September 30, 2022, Adjusted EBITDA loss was $1.5 million, a decrease of $0.5 million, or 25%, compared with an Adjusted EBITDA loss of $2.0 million for the same period last year, after deducting non-cash and one-time expenses.

Net Loss: For the three months ended September 30, 2022, the net loss was $6.9 million, or ($1.98) per share, compared with a net loss of $3.2 million, or a net loss of ($1.61) per share, for the three months ended September 30, 2021.

Financial Results for the Nine Months Ended September 30, 2022:

Revenue: For the nine months ended September 30, 2022, revenue was $6.0 million, an increase of $3.4 million, or 130%, compared with $2.6 million for the same period last year. The increase is due to the winddown of restrictions related to the Covid-19 Pandemic surrounding elective surgeries, enabling an increase in the usage of the Company’s Duramed product lines and ultrasound devices associated with patient recovery. Additionally, due to asset acquisitions in 2021, the Company’s Music City Botanical and Botanical Biotech brands related to an increase of sales compared to 2021 of approximately $2.2 million.

Gross Profit: For the nine months ended September 30, 2022, gross profit was $2.8 million, an increase of $1.0 million, or 59%, compared with $1.7 million for the same period last year. The resulting gross margin was 46%, compared with 66% for the same period last year.

Total Operating Expenses: For the nine months ended September 30, 2022, total operating expenses were $14.3 million, an increase of $5.7 million, or 243%, compared with $8.6 million for the same period last year. The increase in operating expenses was primarily due to the non-cash stock-based compensation expense of $5.1 million.

Operating Loss: For the nine months ended September 30, 2022, operating loss was $11.6 million, an increase of $4.7 million, compared with an operating loss of $6.9 million for the same period last year.

Adjusted EBITDA Loss: For the nine months ended September 30, 2022, Adjusted EBITDA loss was $4.5 million, a decrease of $0.8 million, or 15%, compared with an Adjusted EBITDA loss of $5.3 million for the same period last year, after deducting non-cash and one-time expenses.

Net Loss: For the nine months ended September 30, 2022, net loss was $12.0 million, or ($3.56) per share, compared with $8.2 million, or ($5.39) per share, for the same period last year.

About Can B Corp.

Can B Corp. (OTCQB: CANB) is a health & wellness company providing the highest quality hemp-derived cannabinoid products, including under its own brands of Canbiola, Seven Chakras, NuWellness, Pure Leaf Oil, and Duramed. Can B utilizes multi-channel distribution to reach consumers, including medical facilities, doctor offices, retailers, online and direct. Can B Corp. operates R&D and production facilities in Lacey, WA, and Florida. To learn more about Can B Corp. and our comprehensive line of high-quality products, please visit: Canbiola.com and www.CanBCorp.com, follow Can B Corp on Instagram and Facebook or visit one of the 1,000+ retail outlets that carry Can B Corp. products.

For more information about Can B Corp., please visit: CanBCorp.com

Twitter @CanBCorp

Instagram @canbcorp

Facebook @ Can B Corp

YouTube

[waterchaser]

Not to mention the reverse splits.

[Penny Masters]

Really nothing any longer for CANB to pump. Cannot see how anybody would look at this and take it serious with the massive losses, bloated salaries and dead products.

Peace out

[waterchaser]

Seems the CANB promo is winding down.
As it should be I suppose… it’s hard to defend the indefensible.

[Penny Masters]

Nasty what was done to CANB share holders. Not sure how they are allow to continue with all the RS's they did.

[waterchaser]

I read this back in September:

Smart Money Accumulating in the $3.00-$4.00 Range was a very smart move indeed.

[waterchaser]

Big day-for-this juggernaut! A share (1) has already traded!

[skyhawk66]

Your right, CANB shares Continue to be Calmly Collected and stored away.
After yesterday’s 35% Rally on high volume, only 100 shares traded today.
Proves Investors are holding on to these Golden Shares with a Kung Fu Grip ;)
:
Calm, cool and collected. I know the ENTIRE sector is down and has been for over 2 years so any bad talk is just bullshit rhetoric.

CANB

NASDAQ

[Penny Masters]

The sleek scam artists are everywhere. CANB is no different.

Some should end up in jail for what they did.

Peace out

[waterchaser]

The constant operational losses here could spell the end for this charade.

[Penny Masters]

CANB is a massive shit show. Bloated salaries, products no one wants and is bleeding money.

What could go wrong. Hahahahaha

Peace out

[skyhawk66]

Very Exciting Indeed, can’t twist the Facts CANB Continues to make Massive Strides in the right Direction :)
No Wonder Accumulation Continues Weekly/Monthly…More Facts from the last 2nd Record Quarterly Report, Boy Exciting Times Ahead for CANB for Sure in 2023 :)
$$$$$
CEO is correct in what he said in reduction in cash loss, Smart Moves Continues!
“It is great to see all the challenging work pay off and result in accelerating revenue growth and a reduction in cash losses. “
:

As Forecasted, Another Record Quarterly Revenue Record for CANB!
Can B Corp. Reports Growth of 51% to $2.9 Million Revenue for Third Quarter 2022, the Highest Quarterly Revenue in Company History

Can B Corp
Tue, November 22, 2022 at 9:30 AM
In this article:

Can B Corp

Led by a Significant Increase in Duramed, Music City Botanical and Botanical Biotech Brands

Adjusted EBITDA Loss Decreased by 25% to $1.5 Million

HICKSVILLE, NY, Nov. 22, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Can B Corp. (OTCQB: CANB) (“Can B” or the “Company”), a health and wellness company specializing in developing, producing, and selling hemp-derived cannabinoid products, today announced the Company's financial results for the third quarter and nine months ended September 30, 2022.

Key Financial Highlights for Q3 2022

Revenue increased 51% to $2.9 million

Gross profit increased 36% to $1.9 million

Gross margin decreased to 64.3%

Adjusted EBITDA loss decreased by 25% to $1.5 million

Accounts receivable at $7.0 million

Inventory at $2.3 million

Total assets at $16.7 million

Total stockholders’ equity at $4.5 million

Key Financial Highlights for 9 Months Ended September 30, 2022

Revenue increased 130% to $6.0 million

Gross profit increased 59% to $2.8 million

Gross margin decreased to 46.0%

Adjusted EBITDA loss decreased by 15% to $4.5 million

Key Business Highlights for Q3 2022

Signed Manufacturing and Distribution Agreement for Superfood Products with Forever Brands and Brooke Burke via BB Body, Inc.

Consolidated Hemp Division Operations in Colorado

Management Commentary

Marco Alfonsi, Can B’s Chief Executive Officer, stated, “We are thrilled with our tremendous quarterly results, having achieved the highest quarterly revenue in our company history. We generated $2.9 million in quarterly revenue while reducing our cash burn as demonstrated by the 25% decrease in Adjusted EBITDA. Our team made great strides over the past several months integrating and ramping up the various operations we strategically acquired over the past year to complete our vertical processing capabilities.”

Alfonsi concluded, “We had a vision and were confident in the assets we were assembling over the past year. It is great to see all the challenging work pay off and result in accelerating revenue growth and a reduction in cash losses.

[Penny Masters]

Your excited about the 12 million in losses? Too funny this bullshit charade goes on.

Wonder what the next sector CANB will be in as they failed miserably in this sector.

Peace out

[skyhawk66]

So Exiting, CANB has got its Investors on the Edge. Who can blame, 3rd Record Quarter Fast Approaches :) $$$$

In the meantime…..Accumulation Continues Daily,Weekly, And Monthly….Period.

[waterchaser]

Yep, it's hard to look away at a train wreck like CANB.

[skyhawk66]

Couldn’t Agree more BG, spot on.

Glad I’m loading Up along with others at these discounted levels.

In the mean time, All Eyes remain laser focused on CANB $$$

[badguy3101]

Calm, cool and collected. I know the ENTIRE sector is down and has been for over 2 years so any bad talk is just bullshit rhetoric.

CANB

NASDAQ



The Badguy